Added to YB: 2016-01-22
Pitch date: 2016-01-22
PGNX:US [bullish]
Progenics Pharmaceuticals, Inc.
-32.9%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Progenics Pharmaceuticals, Inc., an oncology company, engages in the development and commercialization of various targeted medicines and artificial intelligence to find, fight, and follow cancer.
Market Cap
$355.0M
Pitch Price
$6.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-5.30
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Progenics Pharmaceuticals PGNX:US
A summary for this pitch has not been created yet.
Read full article (0 min)